Journal
JOURNAL OF MATERNAL-FETAL & NEONATAL MEDICINE
Volume 35, Issue 25, Pages 6380-6387Publisher
TAYLOR & FRANCIS LTD
DOI: 10.1080/14767058.2021.1914572
Keywords
Metabolomics; congenital heart defect; metabolites; mass spectrometry; nuclear magnetic resonance
Categories
Ask authors/readers for more resources
This study aimed to identify maternal urine metabolomic biomarkers during the second and third trimester for detecting fetal congenital heart defects. Results showed significant alterations in metabolite concentrations in pregnancies with CHDs, with methionine being the most significantly altered. A predictive algorithm combining metabolites and US four-chamber view achieved high sensitivity and specificity in detecting isolated CHDs. The dysregulation of lipid- and folate metabolism in CHD pregnancies supports existing data on the mechanism of CHDs.
Objective To identify maternal second and third trimester urine metabolomic biomarkers for the detection of fetal congenital heart defects (CHDs). Study design This was a prospective study. Metabolomic analysis of randomly collected maternal urine was performed, comparing pregnancies with isolated, non-syndromic CHDs versus unaffected controls. Mass spectrometry (liquid chromatography and direct injection and tandem mass spectrometry, LC-MS-MS) as well as nuclear magnetic resonance spectrometry, H-1 NMR, were used to perform the analyses between 14 0/7 and 37 0/7 weeks gestation. A total of 36 CHD cases and 41 controls were compared. Predictive algorithms using urine markers alone or combined with, clinical and ultrasound (US) (four-chamber view) predictors were developed and compared. Results A total of 222 metabolites were identified, of which 16 were overlapping between the two platforms. Twenty-three metabolite concentrations were found in significantly altered in CHD gestations on univariate analysis. The concentration of methionine was most significantly altered. A predictive algorithm combining metabolites (histamine, choline, glucose, formate, methionine, and carnitine) plus US four-chamber view achieved an AUC = 0.894; 95% CI, 0814-0.973 with a sensitivity of 83.8% and specificity of 87.8%. Enrichment pathway analysis identified several lipid related pathways that are dysregulated in CHD, including phospholipid biosynthesis, phosphatidylcholine biosynthesis, phosphatidylethanolamine biosynthesis, and fatty acid metabolism. This could be consistent with the increased risk of CHD in diabetic pregnancies. Conclusions We report a novel, noninvasive approach, based on the analysis of maternal urine for isolated CHD detection. Further, the dysregulation of lipid- and folate metabolism appears to support prior data on the mechanism of CHD.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available